Kod : T22873 Barkod : 8697432095616 Havale olarak 11,14 TL daha az de
Key highlights from the trial: Patients on CagriSema lost an average of 14.2% body weight, beating Wegovys 10.2% The drug showed stronger HbA1c reduction, improving blood sugar control CagriSema combines semaglutide and cagrilintide in a single weekly injection Results support Novo Nordisks push toward regulatory approval These findings could reshape competition in the obesity and diabetes treatment space as drugmakers race to deliver more effective therapies
So just like during puberty, hormonal fluctuations are mainly to blame
For a low-calorie twist on the classic drink, opt for a dry martini, which uses more gin and less vermouth
Sipping ginger tea or cold water between small bites can also help
Potential Side Effects and Considerations While IV therapy for weight loss is generally safe, there are potential side effects to be aware of